The wound experts at University Foot and Ankle Institute (UFAI) share in-depth experience healing most foot and leg wound types — including diabetic foot ulcers, pressure ulcers, and venous leg ulcers (VLU) — which affect about 2.5 million patients in the United States annually.
Our podiatrists approach these chronic wounds with a combination of two therapies: a bilayered living cellular construct (BLCC) and an acellular fetal bovine collagen dressing (FBCD).
In layperson’s terms, BLCC is compression therapy and BLCC is collagen treatment. Both are challenging for healthcare professionals.
The use of collagen dressings in conjunction with other treatment modalities like negative pressure wound therapy (NPWT) can help facilitate adherence of the tissue layers in the wound bed and improve healing.